THE RISE OF FAMILY OFFICE INVESTMENT CLUBS

Tuesday, August 20th, 2019

Family Office Networks announced today that it has launched new Investment Clubs to help its members share investment ideas, experiences, education and information in a confidential setting. “For generations family offices have invested in alternative investments such as real estate, private equity and venture capitalism…

FON TV
SCN’s Julia Sun Sits Down With Andrew Schneider, The Founder
Tuesday, August 20th, 2019
SCN’s Julia Sun sits down with Andrew Schneider, the Founder & CEO of Family Office Networks, to discuss the Family Office community he has built.

FON NEWS
LOS ANGELES FAMILY OFFICE ASSOCIATION LAUNCHES
Tuesday, August 20th, 2019
Los Angeles Family Office Association launches as networking resource for wealthy families and their advisors.

FON REAL ESTATE NEWS
How To Invest In Industrial Real Estate
Tuesday, August 20th, 2019

Healthcare Opportunity Mixer

Tuesday, September 24th, 2019

VIEW DETAILS

Benefit From Failure

Wednesday, September 25th, 2019

VIEW DETAILS

Discount The Weed

Wednesday, September 25th, 2019

VIEW DETAILS

PAGANI HUAYRA HYPERCAR $25K PER MONTH

FON LUXURY

FAMILY OFFICE NETWORKS MAGAZINE

FON MAGAZINE

FAMILY OFFICE NETWORKS PHILANTHROPY

FON PHILANTHROPY

Anthemis releases Embedded Finance, a white paper on the future of the economy

Anthemis releases Embedded Finance, a white paper on the future of the economy Anthemis sees the future state of financial services as embedded, augmented and ubiquitous. Rather than finance being discrete, Anthemis believes it is becoming an intimate part of the products and services that drive our economies — an often invisible but critical societal...
Read More

How to Invest in Biotech Series – Phases, Stages, and Pitfalls

How to Invest in Biotech Series – Phases, Stages, and Pitfalls By Marc Appel, CEO, Orange Grove Bio Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia, a serious yet the most common type of childhood cancer. Her cancer was resistant to traditional treatments and her prognosis was poor. In...
Read More

BioXyTran, Inc. — Tissue Regeneration for Life

BioXyTran, Inc. — Tissue Regeneration for Life Bioxytran Inc. (OTC: BIXT) is a late stage biotechnology company that is developing a first-in-class oxygen treatment platform for victims of brain stroke trauma. The company’s lead drug candidate, BXT-25, is getting ready to proceed to testing.  BXT-25 has many properties of an existing, well tested drug, called...
Read More

Orange Grove Bio: Filling the Gap in Preclinical Drug Development

Orange Grove Bio: Filling the Gap in Preclinical Drug Development Future Orange Grove Bio is a preclinical drug development company focused on driving down the cost of drug development and taking advantage of the exceptional science developed at universities across the country. Preclinical biopharma today represents one of the best opportunities in life sciences today....
Read More

Selecting Therapies for Cancer Patients: Past, Present, and Future

Selecting Therapies for Cancer Patients: Past, Present, and Future Clifford Reid, PhD We are in the middle of a revolution in DNA sequencing, which has ushered in the era of precision medicine in cancer. Unfortunately, the impact of precision medicine has been quite limited, reaching only about 15% of cancer patients, and benefitting only about...
Read More

An Interview with Kristin Bedard PhD, Chief Scientific Officer Kineta Immuno-Oncology Part 2

An Interview with Kristin Bedard PhD, Chief Scientific Officer Kineta Immuno-Oncology. KINETA, INC. – Innovation in Cancer Care, New Drugs in High Need Areas (PART 2). Part 2 In two previous articles, our readers were introduced to the Kineta, Inc. CEO Shawn Iadonato and Kristin Bedard PhD, the Chief Scientific Officer at the company.  In...
Read More